Donor Screening Recommendations to Reduce the Risk of Transmission of Zika Virus by Human Cells Tissues and Cellular and Tissue-Based Products

The U.S. Food and Drug Administration released this guidance for establishments that make donor eligibility determinations for donors of human cells, tissues, and cellular and tissue-based products for screening donors for evidence of, and risk factors for, infection with Zika virus.
You must Login to add a comment
  • This item doesn't have any comments

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.